For citations:
Morozova E.V., Tsvetkov N.Yu., Barabanshchikova M.V., Yurovskaya K.S., Moiseev I.S. New perspectives in the treatment of patients with intermediate-2 and high-risk myelodysplastic syndrome. Oncohematology. 2022;17(4):106-117. (In Russ.) https://doi.org/10.17650/1818-8346-2022-17-4-106-117